查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1482439

塑身设备市场：依产品类型、最终用户、地区：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031 年

Body Contouring Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 302 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究对全球塑身设备市场进行深入分析，深入瞭解市场动态、成长动力、课题和新兴趋势。该报告提供了详细的数据和统计数据以引导市场格局，并为利害关係人提供全面的指南。

预计全球塑身设备市场在 2024 年至 2031 年预测期内将显着成长，复合年增长率为 15%。该市场预计将从 2024 年的 18 亿美元扩大到 2031 年的 48 亿美元。

重要见解

  • 预计市场规模（2024年）：18亿美元
  • 预计市值（2031年）48亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：15%

塑身设备市场 – 研究范围

身体轮廓设备包括一系列旨在塑造和重新定义身体轮廓的非侵入性和微创手术。这些设备针对腹部、大腿、上臂和臀部等区域，并列出了减脂、紧肤和减少脂肪团的解决方案。

人们对外观美感的日益重视，加上美容手术技术的进步，正在推动对塑身设备的需求。肥胖率上升、可支配收入增加以及美容护理意识不断增强等因素推动了市场的成长。

市场驱动因素：

身体轮廓设备市场受到多种因素的推动，例如世界上肥胖和超重人口的增加。随着人们寻求塑造更优美体形的方法，对非手术身体轮廓手术的需求不断增加。射频、超音波和冷冻溶脂设备等技术的进步为传统外科手术提供了有效且安全的替代方案。

此外，人口老化和对更年轻外表的渴望正在推动对紧肤和减少脂肪团治疗的需求。此外，融资选择的可用性和医疗旅游的盛行进一步促进了市场的成长。

市场限制因素：

儘管成长轨迹充满希望，但轮廓设备市场仍面临一定的课题。对非侵入性手术的安全性和有效性的担忧可能会阻碍其进入市场，尤其是在谨慎的消费者中。整容手术的监管监督和报销限制也为市场扩张带来了课题。

此外，与先进的轮廓设备和治疗相关的高成本可能会限制某些患者群体的使用。此外，注射和外科手术等替代疗法的出现可能会转移非侵入性身体轮廓设备的市场占有率。

市场机会：

塑身设备市场存在许多创新和扩张的机会。技术进步，例如结合不同能源的多模式方法，可以改善治疗结果和患者满意度。此外，脸部年轻化和阴道年轻化等超越传统身体轮廓的应用正在扩大市场范围。

从地区来看，由于可支配收入的增加、生活方式的改变以及美容程序意识的提高，亚太和拉丁美洲新兴市场具有强劲的成长潜力。策略合作伙伴关係、合併和收购使公司能够扩大其产品组合和地理分布并提高市场渗透率。

本报告解决的关键问题

  • 2024年至2031年塑身设备市场的预期复合年增长率是多少？
  • 推动塑身设备市场成长的关键因素是什么？
  • 哪个地区在塑身设备市场中占最大的市场占有率？
  • 全球塑身设备市场的主要参与者有哪些？
  • 主要参与者正在采取哪些策略来维持塑身设备市场的成长？

目录

第一章执行摘要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第三章市场背景

  • 市场动态
  • 情景预测
  • 机会图分析
  • 产品生命週期分析
  • 供应链分析
  • 投资可行性矩阵
  • 价值链分析
  • PESTLE 与 Porter 分析
  • 监管状况
  • 区域母公司市场展望
  • 生产与消费统计
  • 进出口统计

第四章全球塑身设备市场分析

  • 2019-2023 年过去市场规模（百万美元）与数量（单位）分析
  • 2024-2031 年当前市场规模价值（百万美元）和数量（单位）的分析和预测
  • 同比增长趋势分析
  • 绝对量机会分析

第五章全球塑身设备市场类型分析

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）和数量（单位）分析（依类型）
  • 2024-2031 年依类型划分的当前市场规模价值（百万美元）和数量（件）的分析和预测
    • 无创和微创设备
    • 侵入性装置
  • 2019-2023年依类型年成长趋势分析
  • 2024-2031 年依类型划分的绝对数量机会分析

第 6 章：依应用类型划分的全球塑身设备市场分析

  • 简介/主要发现
  • 2019-2023 年历史市场规模（百万美元）和数量（单位）分析（依应用类型）
  • 2024-2031 年依应用类型划分的当前市场规模价值（百万美元）和数量（单位）的分析和预测
    • 非手术皮肤再生
    • 非手术紧肤
    • 橘皮组织治疗
    • 抽脂术
    • 其他
  • 2019-2023 年依应用类型划分的年成长趋势分析
  • 2024-2031 年依应用类型划分的绝对货币机会分析

第七章塑身仪市场区域分析

  • 介绍
  • 2019-2023 年历史市场规模（百万美元）和数量（单位）分析（依地区）
  • 2024-2031 年依地区划分的当前市场规模价值（百万美元）和数量（单位）分析和预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 区域市场吸引力分析

第八章北美塑身设备市场分析：依国家

第九章拉丁美洲塑身设备市场分析：依国家分类

第10章欧洲塑身设备市场分析：依国家分类

第十一章亚太塑身设备市场分析：依国家

第十二章中东和非洲塑身设备市场分析：依国家/地区

第十三章 主要国家塑身仪市场分析

  • 美国
  • 加拿大
  • 巴西
  • 墨西哥
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 中国
  • 日本
  • 韩国
  • 新加坡
  • 泰国
  • 印度尼西亚
  • 澳大利亚
  • 纽西兰
  • 海湾合作委员会国家
  • 南非
  • 以色列

第14章市场结构分析

  • 比赛仪表板
  • 竞争标桿
  • 主要参与者的市场占有率分析

第 15 章 竞争分析

  • 衝突详情
    • Cynosure, Inc.
    • Alma Lasers
    • Allergan Plc
    • Merz Pharma Gmbh
    • Candela Medical Ltd.
    • Solta Medical Bausch Health Companies, Inc.
    • Lutronic Corporation
    • InMode Ltd
    • Fotona
    • Sofwave Medical LTD
    • Sciton Inc
    • Lumenis

第 16 章所使用的假设与缩写词

第17章研究方法论

简介目录
Product Code: PMRREP33175

Persistence Market Research conducts an in-depth analysis of the global Body Contouring Devices Market, offering insights into market dynamics, growth drivers, challenges, and emerging trends. This report serves as a comprehensive guide for stakeholders, providing detailed data and statistics to navigate the market landscape.

The global body contouring devices market is anticipated to witness substantial growth during the forecast period from 2024 to 2031, with a projected CAGR of 15%. The market is estimated to expand from USD 1.8 billion in 2024 to USD 4.8 billion by 2031.

Key Insights:

  • Estimated Market Value (2024): USD 1.8 Billion
  • Projected Market Value (2031): USD 4.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 15%

Body Contouring Devices Market - Report Scope:

Body contouring devices encompass a range of non-invasive and minimally invasive procedures designed to reshape and redefine the body's contours. These devices target areas such as abdomen, thighs, arms, and buttocks, offering solutions for fat reduction, skin tightening, and cellulite reduction.

The growing emphasis on aesthetic appearance, coupled with technological advancements in cosmetic procedures, drives the demand for body contouring devices. Factors such as rising obesity rates, increasing disposable income, and growing awareness about cosmetic treatments contribute to market growth.

Market Growth Drivers:

The body contouring devices market is propelled by several factors, including the rising prevalence of obesity and overweight populations worldwide. As individuals seek ways to achieve a more sculpted physique, the demand for non-surgical body contouring procedures increases. Technological advancements, such as radiofrequency, ultrasound, and cryolipolysis-based devices, offer effective and safer alternatives to traditional surgical procedures.

Moreover, the expanding aging population, coupled with the desire for youthful appearance, drives demand for skin tightening and cellulite reduction treatments. Additionally, the availability of financing options and the proliferation of medical tourism further contribute to market growth.

Market Restraints:

Despite its promising growth trajectory, the body contouring devices market faces certain challenges. Concerns regarding the safety and efficacy of non-invasive procedures may hinder market adoption, particularly among cautious consumers. Regulatory scrutiny and reimbursement limitations for cosmetic procedures also pose challenges for market expansion.

Moreover, the high cost associated with advanced body contouring devices and treatments may limit access for certain patient demographics. Additionally, the emergence of alternative treatments, such as injectables and surgical procedures, may divert market share from non-invasive body contouring devices.

Market Opportunities:

The body contouring devices market presents several opportunities for innovation and expansion. Advancements in technology, such as multi-modal approaches combining different energy sources, enhance treatment outcomes and patient satisfaction. Furthermore, expanding applications beyond traditional body contouring, such as facial rejuvenation and vaginal rejuvenation, broaden the market scope.

Geographically, emerging markets in Asia Pacific and Latin America offer significant growth potential due to increasing disposable income, changing lifestyles, and growing awareness about aesthetic procedures. Strategic partnerships, mergers, and acquisitions enable companies to expand their product portfolios and geographic presence, driving market penetration.

Key Questions Addressed in the Report:

  • What is the Expected Value CAGR of the Body Contouring Devices Market from 2024 to 2031?
  • What are the Key Factors Driving the Growth of the Body Contouring Devices Market?
  • Which Region Holds the Largest Market Share in the Body Contouring Devices Market?
  • Who are the Key Players in the Global Body Contouring Devices Market?
  • What Strategies are Adopted by Leading Companies to Sustain Growth in the Body Contouring Devices Market?

Competitive Landscape and Business Strategies:

Prominent players in the body contouring devices market include Alma Lasers, Ltd., Cynosure, Inc. (a subsidiary of Hologic, Inc.), Syneron Medical Ltd. (a subsidiary of Apax Partners), and Lumenis Ltd. These companies focus on product innovation, research and development, and strategic collaborations to maintain market leadership.

Key strategies adopted by leading players include launching advanced body contouring devices with enhanced safety profiles and superior efficacy. Moreover, investment in clinical research and marketing initiatives aimed at increasing patient awareness and education is crucial for market expansion.

Key Companies Profiled:

  • Alma Lasers, Ltd.
  • Cynosure, Inc. (a subsidiary of Hologic, Inc.)
  • Syneron Medical Ltd. (a subsidiary of Apax Partners)
  • Lumenis Ltd.
  • Cutera, Inc.
  • Venus Concept Ltd.
  • Solta Medical, Inc. (a subsidiary of Bausch Health Companies Inc.)
  • InMode Ltd.
  • BTL Industries Inc.
  • Zimmer MedizinSysteme GmbH

Body Contouring Devices Market Segmentation:

By Type

  • Non-invasive and Minimally Invasive Devices
  • Invasive Devices

By Application type

  • Nonsurgical skin Resurfacing
  • Nonsurgical skin tightening
  • Cellulite treatment
  • Liposuction
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Product Life Cycle Analysis
  • 3.5. Supply Chain Analysis
    • 3.5.1. Supply Side Participants and their Roles
      • 3.5.1.1. Producers
      • 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
      • 3.5.1.3. Wholesalers and Distributors
    • 3.5.2. Value Added and Value Created at Node in the Supply Chain
    • 3.5.3. List of Raw Material Suppliers
    • 3.5.4. List of Existing and Potential Buyer's
  • 3.6. Investment Feasibility Matrix
  • 3.7. Value Chain Analysis
    • 3.7.1. Profit Margin Analysis
    • 3.7.2. Wholesalers and Distributors
    • 3.7.3. Retailers
  • 3.8. PESTLE and Porter's Analysis
  • 3.9. Regulatory Landscape
    • 3.9.1. By Key Regions
    • 3.9.2. By Key Countries
  • 3.10. Regional Parent Market Outlook
  • 3.11. Production and Consumption Statistics
  • 3.12. Import and Export Statistics

4. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast, 2024-2031

  • 4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2024-2031
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Type, 2024-2031
    • 5.3.1. Non-invasive and Minimally Invasive Devices
    • 5.3.2. Invasive Devices
  • 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Type, 2024-2031

6. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Application Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Application Type, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Application Type, 2024-2031
    • 6.3.1. Nonsurgical Skin Resurfacing
    • 6.3.2. Nonsurgical Skin Tightening
    • 6.3.3. Cellulite Treatment
    • 6.3.4. Liposuction
    • 6.3.5. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application Type, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application Type, 2024-2031

7. Global Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Region

  • 7.1. Introduction
  • 7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2019-2023
  • 7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2024-2031
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific
    • 7.3.5. MEA
  • 7.4. Market Attractiveness Analysis By Region

8. North America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 8.2.1. By Country
      • 8.2.1.1. U.S.
      • 8.2.1.2. Canada
    • 8.2.2. By Type
    • 8.2.3. By Application Type
  • 8.3. Market Attractiveness Analysis
    • 8.3.1. By Country
    • 8.3.2. By Type
    • 8.3.3. By Application Type
  • 8.4. Key Takeaways

9. Latin America Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 9.2.1. By Country
      • 9.2.1.1. Brazil
      • 9.2.1.2. Mexico
      • 9.2.1.3. Rest of Latin America
    • 9.2.2. By Type
    • 9.2.3. By Application Type
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Type
    • 9.3.3. By Application Type
  • 9.4. Key Takeaways

10. Europe Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 10.2.1. By Country
      • 10.2.1.1. Germany
      • 10.2.1.2. U.K.
      • 10.2.1.3. France
      • 10.2.1.4. Spain
      • 10.2.1.5. Italy
      • 10.2.1.6. Rest of Europe
    • 10.2.2. By Type
    • 10.2.3. By Application Type
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Type
    • 10.3.3. By Application Type
  • 10.4. Key Takeaways

11. Asia Pacific Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 11.2.1. By Country
      • 11.2.1.1. China
      • 11.2.1.2. Japan
      • 11.2.1.3. South Korea
      • 11.2.1.4. Singapore
      • 11.2.1.5. Thailand
      • 11.2.1.6. Indonesia
      • 11.2.1.7. Australia
      • 11.2.1.8. New Zealand
      • 11.2.1.9. Rest of Asia Pacific
    • 11.2.2. By Type
    • 11.2.3. By Application Type
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Type
    • 11.3.3. By Application Type
  • 11.4. Key Takeaways

12. MEA Body Contouring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Country

  • 12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2024-2031
    • 12.2.1. By Country
      • 12.2.1.1. GCC Countries
      • 12.2.1.2. South Africa
      • 12.2.1.3. Israel
      • 12.2.1.4. Rest of MEA
    • 12.2.2. By Type
    • 12.2.3. By Application Type
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Type
    • 12.3.3. By Application Type
  • 12.4. Key Takeaways

13. Key Countries Body Contouring Devices Market Analysis

  • 13.1. U.S.
    • 13.1.1. Pricing Analysis
    • 13.1.2. Market Share Analysis, 2024
      • 13.1.2.1. By Type
      • 13.1.2.2. By Application Type
  • 13.2. Canada
    • 13.2.1. Pricing Analysis
    • 13.2.2. Market Share Analysis, 2024
      • 13.2.2.1. By Type
      • 13.2.2.2. By Application Type
  • 13.3. Brazil
    • 13.3.1. Pricing Analysis
    • 13.3.2. Market Share Analysis, 2024
      • 13.3.2.1. By Type
      • 13.3.2.2. By Application Type
  • 13.4. Mexico
    • 13.4.1. Pricing Analysis
    • 13.4.2. Market Share Analysis, 2024
      • 13.4.2.1. By Type
      • 13.4.2.2. By Application Type
  • 13.5. Germany
    • 13.5.1. Pricing Analysis
    • 13.5.2. Market Share Analysis, 2024
      • 13.5.2.1. By Type
      • 13.5.2.2. By Application Type
  • 13.6. U.K.
    • 13.6.1. Pricing Analysis
    • 13.6.2. Market Share Analysis, 2024
      • 13.6.2.1. By Type
      • 13.6.2.2. By Application Type
  • 13.7. France
    • 13.7.1. Pricing Analysis
    • 13.7.2. Market Share Analysis, 2024
      • 13.7.2.1. By Type
      • 13.7.2.2. By Application Type
  • 13.8. Spain
    • 13.8.1. Pricing Analysis
    • 13.8.2. Market Share Analysis, 2024
      • 13.8.2.1. By Type
      • 13.8.2.2. By Application Type
  • 13.9. Italy
    • 13.9.1. Pricing Analysis
    • 13.9.2. Market Share Analysis, 2024
      • 13.9.2.1. By Type
      • 13.9.2.2. By Application Type
  • 13.10. China
    • 13.10.1. Pricing Analysis
    • 13.10.2. Market Share Analysis, 2024
      • 13.10.2.1. By Type
      • 13.10.2.2. By Application Type
  • 13.11. Japan
    • 13.11.1. Pricing Analysis
    • 13.11.2. Market Share Analysis, 2024
      • 13.11.2.1. By Type
      • 13.11.2.2. By Application Type
  • 13.12. South Korea
    • 13.12.1. Pricing Analysis
    • 13.12.2. Market Share Analysis, 2024
      • 13.12.2.1. By Type
      • 13.12.2.2. By Application Type
  • 13.13. Singapore
    • 13.13.1. Pricing Analysis
    • 13.13.2. Market Share Analysis, 2024
      • 13.13.2.1. By Type
      • 13.13.2.2. By Application Type
  • 13.14. Thailand
    • 13.14.1. Pricing Analysis
    • 13.14.2. Market Share Analysis, 2024
      • 13.14.2.1. By Type
      • 13.14.2.2. By Application Type
  • 13.15. Indonesia
    • 13.15.1. Pricing Analysis
    • 13.15.2. Market Share Analysis, 2024
      • 13.15.2.1. By Type
      • 13.15.2.2. By Application Type
  • 13.16. Australia
    • 13.16.1. Pricing Analysis
    • 13.16.2. Market Share Analysis, 2024
      • 13.16.2.1. By Type
      • 13.16.2.2. By Application Type
  • 13.17. New Zealand
    • 13.17.1. Pricing Analysis
    • 13.17.2. Market Share Analysis, 2024
      • 13.17.2.1. By Type
      • 13.17.2.2. By Application Type
  • 13.18. GCC Countries
    • 13.18.1. Pricing Analysis
    • 13.18.2. Market Share Analysis, 2024
      • 13.18.2.1. By Type
      • 13.18.2.2. By Application Type
  • 13.19. South Africa
    • 13.19.1. Pricing Analysis
    • 13.19.2. Market Share Analysis, 2024
      • 13.19.2.1. By Type
      • 13.19.2.2. By Application Type
  • 13.20. Israel
    • 13.20.1. Pricing Analysis
    • 13.20.2. Market Share Analysis, 2024
      • 13.20.2.1. By Type
      • 13.20.2.2. By Application Type

14. Market Structure Analysis

  • 14.1. Competition Dashboard
  • 14.2. Competition Benchmarking
  • 14.3. Market Share Analysis of Top Players
    • 14.3.1. By Regional
    • 14.3.2. By Type
    • 14.3.3. By Application Type

15. Competition Analysis

  • 15.1. Competition Deep Dive
    • 15.1.1. Cynosure, Inc.
      • 15.1.1.1. Overview
      • 15.1.1.2. Product Portfolio
      • 15.1.1.3. Profitability by Market Segments
      • 15.1.1.4. Sales Footprint
      • 15.1.1.5. Strategy Overview
        • 15.1.1.5.1. Marketing Strategy
        • 15.1.1.5.2. Product Strategy
        • 15.1.1.5.3. Channel Strategy
    • 15.1.2. Alma Lasers
      • 15.1.2.1. Overview
      • 15.1.2.2. Product Portfolio
      • 15.1.2.3. Profitability by Market Segments
      • 15.1.2.4. Sales Footprint
      • 15.1.2.5. Strategy Overview
        • 15.1.2.5.1. Marketing Strategy
        • 15.1.2.5.2. Product Strategy
        • 15.1.2.5.3. Channel Strategy
    • 15.1.3. Allergan Plc
      • 15.1.3.1. Overview
      • 15.1.3.2. Product Portfolio
      • 15.1.3.3. Profitability by Market Segments
      • 15.1.3.4. Sales Footprint
      • 15.1.3.5. Strategy Overview
        • 15.1.3.5.1. Marketing Strategy
        • 15.1.3.5.2. Product Strategy
        • 15.1.3.5.3. Channel Strategy
    • 15.1.4. Merz Pharma Gmbh
      • 15.1.4.1. Overview
      • 15.1.4.2. Product Portfolio
      • 15.1.4.3. Profitability by Market Segments
      • 15.1.4.4. Sales Footprint
      • 15.1.4.5. Strategy Overview
        • 15.1.4.5.1. Marketing Strategy
        • 15.1.4.5.2. Product Strategy
        • 15.1.4.5.3. Channel Strategy
    • 15.1.5. Candela Medical Ltd.
      • 15.1.5.1. Overview
      • 15.1.5.2. Product Portfolio
      • 15.1.5.3. Profitability by Market Segments
      • 15.1.5.4. Sales Footprint
      • 15.1.5.5. Strategy Overview
        • 15.1.5.5.1. Marketing Strategy
        • 15.1.5.5.2. Product Strategy
        • 15.1.5.5.3. Channel Strategy
    • 15.1.6. Solta Medical Bausch Health Companies, Inc.
      • 15.1.6.1. Overview
      • 15.1.6.2. Product Portfolio
      • 15.1.6.3. Profitability by Market Segments
      • 15.1.6.4. Sales Footprint
      • 15.1.6.5. Strategy Overview
        • 15.1.6.5.1. Marketing Strategy
        • 15.1.6.5.2. Product Strategy
        • 15.1.6.5.3. Channel Strategy
    • 15.1.7. Lutronic Corporation
      • 15.1.7.1. Overview
      • 15.1.7.2. Product Portfolio
      • 15.1.7.3. Profitability by Market Segments
      • 15.1.7.4. Sales Footprint
      • 15.1.7.5. Strategy Overview
        • 15.1.7.5.1. Marketing Strategy
        • 15.1.7.5.2. Product Strategy
        • 15.1.7.5.3. Channel Strategy
    • 15.1.8. InMode Ltd
      • 15.1.8.1. Overview
      • 15.1.8.2. Product Portfolio
      • 15.1.8.3. Profitability by Market Segments
      • 15.1.8.4. Sales Footprint
      • 15.1.8.5. Strategy Overview
        • 15.1.8.5.1. Marketing Strategy
        • 15.1.8.5.2. Product Strategy
        • 15.1.8.5.3. Channel Strategy
    • 15.1.9. Fotona
      • 15.1.9.1. Overview
      • 15.1.9.2. Product Portfolio
      • 15.1.9.3. Profitability by Market Segments
      • 15.1.9.4. Sales Footprint
      • 15.1.9.5. Strategy Overview
        • 15.1.9.5.1. Marketing Strategy
        • 15.1.9.5.2. Product Strategy
        • 15.1.9.5.3. Channel Strategy
    • 15.1.10. Sofwave Medical LTD
      • 15.1.10.1. Overview
      • 15.1.10.2. Product Portfolio
      • 15.1.10.3. Profitability by Market Segments
      • 15.1.10.4. Sales Footprint
      • 15.1.10.5. Strategy Overview
        • 15.1.10.5.1. Marketing Strategy
        • 15.1.10.5.2. Product Strategy
        • 15.1.10.5.3. Channel Strategy
    • 15.1.11. Sciton Inc
      • 15.1.11.1. Overview
      • 15.1.11.2. Product Portfolio
      • 15.1.11.3. Profitability by Market Segments
      • 15.1.11.4. Sales Footprint
      • 15.1.11.5. Strategy Overview
        • 15.1.11.5.1. Marketing Strategy
        • 15.1.11.5.2. Product Strategy
        • 15.1.11.5.3. Channel Strategy
    • 15.1.12. Lumenis
      • 15.1.12.1. Overview
      • 15.1.12.2. Product Portfolio
      • 15.1.12.3. Profitability by Market Segments
      • 15.1.12.4. Sales Footprint
      • 15.1.12.5. Strategy Overview
        • 15.1.12.5.1. Marketing Strategy
        • 15.1.12.5.2. Product Strategy
        • 15.1.12.5.3. Channel Strategy

16. Assumptions & Acronyms Used

17. Research Methodology